- pause slideshow
David Jones, editor of the Journal of Pharmacy and Pharmacology, wins APS Innovative Science 2017 award Subscription
David Jones, editor of the Royal Pharmaceutical Society (RPS) Journal of Pharmacy and Pharmacology (JPP) and pro-vice chancellor (Education and Students) at Queen’s University, Belfast, has received The Academy of Pharmaceutical Sciences (APS) Innovative Science 2017 award.
Antidepressant use increases the risk of mortality and new cardiovascular events, according to a study published in Psychotherapy and Psychosomatics
All women who go into labour before 37 weeks of pregnancy should be offered antibiotics to prevent a potential transmission of Group B streptococcal disease to their babies, the Royal College of Obstetricians and Gynaecologists has said in revised guidelines.
Pharmacists and care home staff are to be given additional training to spot signs of sepsis in patients, health secretary Jeremy Hunt has announced.
Public Health England and NHS England have launched a drive to improve detection and treatment of risk factors for cardiovascular disease, including more blood pressure testing and treatment in pharmacies and increasing update of NHS Health Checks.
The European Medicines Agency (EMA) is to host a summit meeting with doctors’ and patients’ organisations, academics, EU member states and the World Health Organization (WHO) to discuss how collaboration can help tackle antimicrobial resistance (AMR).
Pharmacists are to use hand-held devices to test patients for atrial fibrillation (AF) as part of a hi-tech partnership in London.
Pharmacists have a key role to play in reducing health inequalities, Steve Brine told the Public Health England (PHE) annual conference.
The General Pharmaceutical Council has approved in principle updated standards for the initial education and training of pharmacy technicians.
The National Institute for Health and Care Excellence (NICE) has again rejected ixazomib (Ninlaro) in combination with lenalidomide and dexamethasone (IRd) for the treatment of patients with relapsed or refractory multiple myeloma who have received one or more previous therapies.
Users of e-cigarettes containing nicotine experience “significant” increased stiffening of the arteries, while blood pressure and heart rate also rise, according to the results of a Swedish study.
Data from two clinical trials have shown that second-generation ALK inhibitor alectinib (Alecensa, Roche) reduces central nervous system progression in ALK-positive non-small cell lung carcinoma.
Pharmacists have been warned to be aware of possible wrong labelling on a number of batches of drugs including medicines to treat epilepsy, anxiety and depression.
The European Medicines Agency (EMA) has launched a survey for patients, pharmacists, doctors, nurses and other healthcare professionals to test their awareness of the arrangements for reporting drug reactions.
Pembrolizumab — marketed as Keytruda — has been given approval for use across Europe for some patients with a specific kind of bladder cancer, following a decision by the European Commission.
The National Institute for Health and Care Excellence’s guidance will help healthcare professionals reduce long waits between symptoms and diagnosis for women with the chronic condition.
Local resources to help support people to have better mental health have been produced, Public Health England (PHE) has announced.
The Food and Drug Administration has approved the use of gemtuzumab (Mylotarg) for the treatment of adults with acute myeloid leukaemia whose tumours express the CD33 antigen.
Royal Pharmaceutical Society announces new chief scientist, Gino Martini.
A National Pharmacy Association (NPA) survey found that pharmacists believe Pharmacy2U, Britain’s largest online pharmacy, has been sending out unsolicited marketing material that is confusing patients.
Side effect of GilenyaSubscription
Side effects of ZytigaSubscription
NICE does not recommend ibrutinibSubscription
February 2016: SMC decisionsSubscription
New indication for InegySubscription
CPPE Prescriber's guideSubscription
NICE recommends ezetimibeSubscription
'Be Clear on Cancer' resourcesSubscription
Ativan is back in stockSubscription
Side effects of FruseneSubscription
Nplate indication extendedSubscription
Isoflurane not recommended for childrenSubscription
Glucose monitoring system recommended by NICESubscription
Etoposide SPC updateSubscription
Fluoxetine not recommended during pregnancySubscription